The clinical subtypes of breast cancer are traditionally defined based on the expression status of three receptors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [10,11]. The gene discussed is ERBB2; the disease is breast carcinoma.